Printer Friendly

BIOSENSOR CORPORATION ANNOUNCES RESULTS

 PLYMOUTH, Minn., Oct. 18 /PRNewswire/ -- Biosensor Corporation announced sales revenues of $430,000 and a loss of $83,000 ($0.04 per share) for the first quarter ended Aug. 31, 1993. In the first quarter ended Aug. 31, 1992, sales revenues were $728,000 and earnings were $48,000 ($0.02 per share). Revenues and earnings were lower in the first quarter ended Aug. 31, 1993, because of concerns by physicians about United States and German healthcare reforms and the initial effects of reorganizing the United States sales force to include direct sales representatives. The decrease is also due, in part, to intensifying competition. Sales are expected to increase in the second quarter.
 Biosensor Corporation, a Plymouth-based company, develops, manufactures and sells diagnostic equipment for physicians' offices, clinics and hospitals. The 24-hour ambulatory cardiac monitoring, pulmonary function, EKG and ambulatory blood pressure systems operate independently or in unison on an IBM compatible office computer.
 BIOSENSOR CORPORATION
 Condensed Statements of Operations
 First Quarter Ended
 8/31/93 8/31/92
 Sales $430,000 $728,000
 Net income (loss) (83,000) 48,000
 Income (loss) per share $(.04) $.02
 -0- 10/18/93
 /CONTACT: Michelle Hayden of Biosensor, 612-449-9100/


CO: Biosensor Corporation ST: Minnesota IN: MTC SU: ERN

DB-DS -- MN022 -- 3563 10/18/93 16:22 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 18, 1993
Words:215
Previous Article:EMPI REPORTS STRONG SALES AND EARNINGS GAINS FOR 1993 THIRD QUARTER
Next Article:TRIBUNE, TICKETMASTER, AMERICA ONLINE JOIN TO ALLOW ONLINE SALES OF EVENT, CONCERT TICKETS AND MERCHANDISE
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters